Pluri (PLUR) Other Non-Current Liabilities (2013 - 2025)
Pluri (PLUR) posted quarterly Other Non-Current Liabilities of $263000.0 for Q1 2025, down 30.79% quarter-over-quarter from $380000.0 in Q3 2020.
Pluri (PLUR) Other Non-Current Liabilities (2013 - 2025) Analysis & Trends
Pluri (PLUR) has reported Other Non-Current Liabilities for 9 consecutive years, with $263000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Other Non-Current Liabilities changed N/A year-over-year to $263000.0; the TTM figure through Mar 2025 stood at $263000.0 (changed N/A YoY), while the FY2019 annual figure was $381000.0, down 51.03% from the prior year.
- Other Non-Current Liabilities eased to $263000.0 in Q1 2025 per PLUR's latest filing, from $380000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $263000.0 in Q1 2025 and bottomed at $263000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 263,000.00 |
| Sep 30, 2020 | 380,000.00 |
| Jun 30, 2019 | 381,000.00 |
| Mar 31, 2019 | 705,000.00 |
| Dec 31, 2018 | 765,000.00 |
| Sep 30, 2018 | 825,000.00 |
| Jun 30, 2018 | 778,000.00 |
| Mar 31, 2018 | 838,000.00 |
| Dec 31, 2017 | 897,000.00 |
| Sep 30, 2017 | 869,000.00 |
| Jun 30, 2017 | 929,000.00 |
| Mar 31, 2017 | 920,000.00 |
| Dec 31, 2016 | 980,000.00 |
| Sep 30, 2016 | 1.04 Mn |
| Jun 30, 2016 | 1.10 Mn |
| Dec 31, 2015 | 1.22 Mn |
| Sep 30, 2015 | 481,000.00 |
| Jun 30, 2015 | 502,000.00 |
| Dec 31, 2014 | 544,000.00 |
| Sep 30, 2014 | 566,000.00 |